Ploidy as a predictive biomarker for gemcitabine sensitivity in triple-negative breast cancers

被引：0
|
作者：
Tagal, Vural
Cole, Jackson P.
Miroshnychenko, Daria
Marusyk, Andriy
Andor, Noemi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MR Imaging Features of Triple-Negative Breast Cancers
    Sung, Janice S.
    Jochelson, Maxine S.
    Brennan, Sandra
    Joo, Sandra
    Wen, Yong H.
    Moskowitz, Chaya
    Zheng, Junting
    Dershaw, D. David
    Morris, Elizabeth A.
    BREAST JOURNAL, 2013, 19 (06): : 643 - 649
  • [22] Increased phosphorylation of Akt in triple-negative breast cancers
    Umemura, Shinobu
    Yoshida, Sei
    Ohta, Yoshikazu
    Naito, Kenichiro
    Osamura, R. Yoshiyuki
    Tokuda, Yutaka
    CANCER SCIENCE, 2007, 98 (12) : 1889 - 1892
  • [23] Triple-negative breast cancers — a panoply of cancer types
    Fresia Pareja
    Jorge S. Reis-Filho
    Nature Reviews Clinical Oncology, 2018, 15 : 347 - 348
  • [24] Endogenous NIS Expression in Triple-Negative Breast Cancers
    Corinne Renier
    Chen Yao
    Michael Goris
    Malavika Ghosh
    Laurence Katznelson
    Kent Nowles
    Sanjiv S. Gambhir
    Irene Wapnir
    Annals of Surgical Oncology, 2009, 16
  • [25] Endogenous NIS Expression in Triple-Negative Breast Cancers
    Renier, Corinne
    Yao, Chen
    Goris, Michael
    Ghosh, Malavika
    Katznelson, Laurence
    Nowles, Kent
    Gambhir, Sanjiv S.
    Wapnir, Irene
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) : 962 - 968
  • [26] Endocan as a prognostic biomarker of triple-negative breast cancer
    Sagara, Atsunobu
    Igarashi, Katsuhide
    Otsuka, Maky
    Kodama, Akihiro
    Yamashita, Mutsumi
    Sugiura, Rei
    Karasawa, Takeshi
    Arakawa, Kazuhiko
    Narita, Michiko
    Kuzumaki, Naoko
    Narita, Minoru
    Kato, Yoshinori
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 269 - 278
  • [27] Endocan as a prognostic biomarker of triple-negative breast cancer
    Atsunobu Sagara
    Katsuhide Igarashi
    Maky Otsuka
    Akihiro Kodama
    Mutsumi Yamashita
    Rei Sugiura
    Takeshi Karasawa
    Kazuhiko Arakawa
    Michiko Narita
    Naoko Kuzumaki
    Minoru Narita
    Yoshinori Kato
    Breast Cancer Research and Treatment, 2017, 161 : 269 - 278
  • [28] Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer
    Hu, Xichun
    Xu, Binghe
    Cai, Li
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Jian
    Teng, Yuee
    Tong, Zhongsheng
    Pan, Yueyin
    Yin, Yongmei
    Wu, Changping
    Jiang, Zefei
    Wang, Xiaojia
    Lou, Guyin
    Liu, Donggeng
    Feng, Jifeng
    Luo, Jianfeng
    Wu, Jiong
    Shao, Zhimin
    Ragaz, Joseph
    CANCER RESEARCH, 2015, 75
  • [29] New predictive markers for dasatinib responsiveness in triple-negative breast cancer: A biomarker discovery study
    Ortega-Alvarez, Daniel
    Tebar, David
    Casado, Marta
    Castillo, Elena
    Guardia, Cristina
    Olivares-Osuna, David
    Musulen, Eva
    Mereu, Elisabetta
    Luengo, Gines
    Galan-Moya, Eva M.
    Rodilla, Veronica
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer
    Anborgh, Pieter H.
    Lee, Danny J.
    Stam, Pieter F.
    Tuck, Alan B.
    Chambers, Ann F.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (08) : 727 - 734
12345